US 7763719
Variants of humanized anti-carcinoma MAb CC49
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 7763719 (Variants of humanized anti-carcinoma MAb CC49) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K49/0002, A61K51/1045